Nivolumab in Combination With GDP/ L-asparaginase in NK/ T-cell Lymphoma
Condition: NK/T Cell Lymphoma Interventions: Drug: IV Nivolumab; Drug: IV Gemcitabine; Drug: IV Cisplatin; Drug: IV/PO Dexamethasone; Drug: IV L-asparaginase Sponsors: National Cancer Centre, Singapore; Bristol-Myers Squibb Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Dexamethasone | Lymphoma | Research | Singapore Health | T-cell Lymphoma